The European Medicines Agency is seeking a positive opinion on ruxolitinib cream, with final approval resting with the executive branch.

The entities involved

• European Medicines Agency →

  highest regulatory authority on medicines in the European Union

  • EMA adopted a negative opinion on MAA for Omeros Corporation, while Pomerantz LLP confirmed its global office locations.Thu 15:51
  • OCS is seeking Priority Medicines and Breakthrough Therapy designations for Privosegtor for optic neuritis from the FDA and EMA.Thu 12:31
• Incyte →

  American pharmaceutical company

  • Genmab and Incyte have entered into a collaboration to evaluate new cancer treatments.Sat 11:54
  • Truist Financial, Leerink partners, and Morgan Stanley have raised price targets and weighed in on Incyte stock.Sat 08:28
• European Commission →

  executive branch of the European Union

  • Czech Republic politicians, including Andrej Babiš, held talks regarding a dispute over EU budget management while attending a forum.11:47
  • A consultation involving the European Commission aims to exclude Dutch-owned pelagic fleet from EU review.10:19
• European Medicines Agency →

  highest regulatory authority on medicines in the European Union

  • Reports indicate Europe-wide drug shortages are occurring due to production limitations and high demand, monitored by the European Medicines Agency.Sat 06:52

Related events

• Both the FDA and the European Medicines Agency govern drug approval processes.Aug 12